Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any changes to our recommendations over the previous week. We include this table at the bottom of the Weekly Summary, and provide a link here at the top to the Stock Recommendations Tracker.
Cabot Weekly Review (Video)
In this week’s stock market video, Tyler Laundon scratches the surface of the June inflation data and discusses how the market has interpreted it and where investors see the Fed taking interest rates at the upcoming FOMC meeting in late-July. Tyler then gets into a number of stocks from different industries that look good, including conservative names in the healthcare and retail industries as well as a few higher growth software and energy names.
UPCOMING CABOT EVENTS:
The #1 Way to Profit From Earnings Season
FREE MEMBER BRIEFING: July 21, 2022 Sign up now.
Cabot Prime Insider Live Analyst Briefing with Q&A: 3rd Quarter 2022
FREE WEBINAR: July 13, 2022 Sign up now.
Advisory Services
Cabot Growth Investor
Bi-weekly Update July 22: The major indexes had another good day, today—both the Dow and Nasdaq rose 162 points.
Bi-weekly Issue June 30: The first half of the year is in the books, and it was a doozy, but we’re glad we’ve been able to sidestep a good chunk of the historic damage. Now the focus is on what’s next, and it’s important to respect the evidence today (we’re remaining highly defensive) but also stay flexible; we have seen some relative strength in some growth areas and we’re open to whatever comes.
Cabot Top Ten Trader
Weekly Issue July 18: This week’s list has another batch of biotech names (including some speculative high-flyers), though for our Top Pick, we’re going with Acadia Healthcare (ACHC), which offers both reliability and decent growth, and the chart looks ready to run if the market cooperates.
Movers & Shakers July 22: The market’s action has been improving for a few weeks now—nothing dramatic or necessarily decisive, but the “leaders” of the bear phase stopped going down in mid-May; bad news has been absorbed well; and we’ve even seen a few stocks and a couple of sectors poke their heads up as they build bottoms.
Cabot Undervalued Stocks Advisor
Weekly Update July 20: Other than Citigroup’s earnings release and Barrick Gold’s release of preliminary sales data, no other company produced meaningful news. Perhaps this is to be expected when investors are putting immense weight on company-specific results and their respective outlooks.
Monthly Issue July 6: Investors are facing two consensus forecasts that wouldn’t seem to be possible at the same time: pending recession and stable/rising earnings estimates. We look at how our cyclical stocks have been beaten down even as their earnings estimates remain largely steady.
Cabot Stock of the Week
Weekly Issue July 18: This week’s new recommendation is the rare stock that’s already having a very good year – and is still undervalued. It’s a stock that was in our Stock of the Week portfolio not long ago and has demonstrated enough strength of late to gain re-entry.
Cabot Explorer
Bi-weekly Issue July 21: Stocks are on track to post gains for July as Explorer recommendations have a good week with new pick Centrus Energy (LEU) up 20% followed by Cloudflare (NET), up 15%. Now, we head to Germany for today’s pick.
Bi-weekly Update June 30: The S&P 500 is down about 20% so far this year, putting it on pace for the worst first half in five decades. The return of inflation, a weaker Chinese economy and the Ukraine conflict have all hit growth and weighed on stocks.
Cabot Small-Cap Confidential
Weekly Update July 21: This is the million-dollar question: With incoming data anything but straightforward the Fed is trying to thread the needle ever so gently to guide the economy down to a soft landing.
Monthly Issue July 7: There are hundreds of thousands of people around the world dealing with end-stage organ failure. The underlying causes are demographic trends contributing to chronic disease.
Cabot Dividend Investor
Weekly Update July 20: The market has been strong over the last month. In fact, the S&P 500 has rebounded more than 9% from the June lows. Is this rally for real?
Monthly Issue June 8: It’s a raging bear market in technology. But technology has been by far the best performing sector for well over a decade for good reasons.
Cabot Early Opportunities
Monthly Issue July 20: In the July Issue of Cabot Early Opportunities I snag two stocks from our Watch List and profile three fresh names that have caught my eye. Officially, we add three of these positions to our portfolio, including a rapid growth software stock, an oil and gas producer with a growing midstream asset base, and a rapidly expanding coffee shop.
Cabot Profit Booster
Weekly Issue July 19: This week we are jumping right back into a position in Dollar Tree (DLTR), which is a stock we traded successfully last month.
Alert July 18: On Friday the July calls that we sold against our JD and EQT stock positions expired worthless. Today, both stocks are trading higher, and I want to sell a new set of calls against each. Here are those trades, and approximate prices.
Cabot Micro-Cap Insider
Weekly Update July 20: We didn’t have much news this week, but our companies will start reporting in late July and August. Most of the companies that have reported so far have provided commentary that current economic data doesn’t suggest that a recession is coming.
Monthly Issue July 13: Today, I’m recommending a U.K. natural gas company that is trading at a ridiculously cheap valuation and is run by capable operators who generated a 40x return on their last natural gas company.
Cabot Income Advisor
Weekly Update July 20: The beauty of dividends is that cash keeps rolling in no matter how bad the market stinks. The market has rebounded off the lows of June, for now. There is a window where investors can focus on earnings. The bad 9.1% inflation number came out last week and the Fed appears to have tipped its hand on a 0.75% rate hike later this month. That’s an improvement form speculation of a 1.0% hike after the inflation report.
Monthly Issue June 22: There is overwhelming historical evidence that buying good stocks in bear markets is a highly successful long-term strategy. After all, it’s better to buy stocks cheap. And the market always trends higher over time. The truth is that buying stocks in a bear market is the most successful investment strategy ever devised.
Cabot Turnaround Letter
Weekly Update July 15: Wells Fargo & Company (WFC) reported an encouraging quarter and the shares remain significantly undervalued. Molson Coors (TAP) will return to Super Bowl advertising after a decades-long drought.
Alert July 14: We are moving shares of Credit Suisse (CS) from Buy to Sell.
Monthly Issue June 29: The monthly issue was published this week, with updates on our outlook for the stock and high yield bond markets. Our feature recommendation is ESAB Corporation (ESAB). We comment on the sloppy earnings from Walgreens Boots Alliance (WBA), provide updates on General Electric (GE), Toshiba (TOSYY), Wells Fargo (WFC), Credit Suisse (CS), Xerox (XRX) and TreeHouse Foods (THS).
Cabot Money Club
Stock of the Month July 14: Interest rates are still rising, as the Federal Reserve boosted short-term rates by 75 basis points last month, to try to stem the growth of inflation. There are some signs that it may be working. The 30-year mortgage rate actually saw a couple of decreases early last week, but nudged a bit higher on Friday, to a 5.94% average national rate. And gas prices have declined nationwide to $4.66 per gallon, from $4.68 this time last week. I know that’s not much, but, hey, we’ll take what we can get!
Monthly Magazine June 24: Remember when COVID fees like disinfection charges, personal protection equipment fees, and other miscellaneous charges were added on to restaurant tabs? One of the steepest charges was the “temporary COVID-19 Recovery Charge” of up to 10% of total bills in New York City, approved by the New York City Council. During the pandemic, these fees were life-saving tactics for many businesses—restaurants in particular—that saw their sales drastically erode.
Cabot ETF Strategist
Weekly Update July 19: A recent addition to the Undiscovered Portfolio is the Renaissance IPO ETF (IPO). The name and the ticker are pretty much dead giveaways as to the nature of this fund. It tracks the largest, most liquid, newly listed U.S. IPOs.
Monthly Issue July 12: Since last month’s issue, we’ve seen continued volatility in the U.S. equity markets. Trading volume was among the slowest this year; according to Dow Jones Market Data Group, the typical daily volume in the New York Stock Exchange is close to 5 billion. However, this year, it has been around 4 billion.
Ask the Experts
Cabot Growth Investor
Question: Mike, looks as though money flow is moving from staples and pharmas into the more growth of QQQM. So, is your aggression Index following suit?
Mike: Sure, there are many ways to measure the same thing – we look at the Nasdaq to the XLP, but you can look at the QQQ or some individual stocks, etc. Whatever works for you; we’re not ideological but pragmatic. Intermediate-term it looks like we’re getting a green light. Still a lot of headwinds (long-term trend, few new highs, few breakouts, etc., etc.), but if it holds we’ll probably take another nibble or two. I agree there have been some baby steps in the right direction for sure. Now it’s whether we can build on them through earnings season.
Quarterly Cabot Analyst Meeting
The recording of the Cabot Prime Members Meeting with the Analysts from January 12, 2022 is now available for you to listen to at your convenience—click here for access. This private call with our analysts is one of your exclusive Cabot Prime Pro member benefits.